» Articles » PMID: 1423505

Distribution of the Alpha 2-macroglobulin Receptor/low Density Lipoprotein Receptor-related Protein in Human Tissues

Overview
Journal Cell Tissue Res
Date 1992 Sep 1
PMID 1423505
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

The hepatic alpha 2-macroglobulin receptor (alpha 2MR)/low density lipoprotein receptor-related protein (LRP) binds and endocytoses alpha 2-macroglobulin-proteinase complexes in plasma. In addition, it binds lipoproteins, a novel 40 kDa protein, and complexes between plasminogen activators and plasminogen activator inhibitor type-1. This study shows, for the first time, the tissue distribution of alpha 2MR/LRP as determined by immunohistochemistry with specific monoclonal antibodies. The analysis revealed alpha 2MR/LRP-expression in a restricted spectrum of cell types, including neurons and astrocytes in the central nervous system, epithelial cells of the gastrointestinal tract, smooth muscle cells, fibroblasts, Leydig cells in testis, granulosa cells in ovary, and dendritic interstitial cells of kidney. Monocyte-derived cells displayed marked alpha 2MR/LRP expression in the phagocytes of liver, lung and lymphoid tissues, but no or low expression in antigen-presenting cells including Langerhans' cells of the skin. The high abundance of alpha 2MR/LRP in certain cell types of most organs suggests two main routes for alpha 2MR/LRP-mediated ligand clearance: (1) systemic removal in liver of circulating ligands, and (2) non-hepatic interstitial removal in different organs, including the brain.

Citing Articles

Lipidopathy disrupts peripheral and central amyloid clearance in Alzheimer's disease: Where are our knowledge.

Darabi S, Charkhat Gorgich E, Moradi F, Rustamzadeh A IBRO Neurosci Rep. 2025; 18:191-199.

PMID: 39906286 PMC: 11791331. DOI: 10.1016/j.ibneur.2025.01.004.


Skeletal progenitor LRP1 deficiency causes severe and persistent skeletal defects with Wnt pathway dysregulation.

Alhashmi M, Gremida A, Maharana S, Antonaci M, Kerr A, Fu S Bone Res. 2025; 13(1):17.

PMID: 39865089 PMC: 11770177. DOI: 10.1038/s41413-024-00393-x.


The Low-Density Lipoprotein Receptor-Related Protein-1 Is Essential for Dengue Virus Infection.

Huerta V, Martin A, Sarria M, Guirola O, Yero A, Ramos Y Viruses. 2024; 16(11).

PMID: 39599807 PMC: 11599027. DOI: 10.3390/v16111692.


Advances in Intrathecal Nanoparticle Delivery: Targeting the Blood-Cerebrospinal Fluid Barrier for Enhanced CNS Drug Delivery.

Madadi A, Sohn M Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204177 PMC: 11357388. DOI: 10.3390/ph17081070.


Low-Density Lipoprotein Receptor-Related Protein 1 as a Potential Therapeutic Target in Alzheimer's Disease.

Petralla S, Panayotova M, Franchina E, Fricker G, Puris E Pharmaceutics. 2024; 16(7).

PMID: 39065645 PMC: 11279518. DOI: 10.3390/pharmaceutics16070948.


References
1.
Van Leuven F, Cassiman J, Van Den Berghe H . Demonstration of an alpha2-macroglobulin receptor in human fibroblasts, absent in tumor-derived cell lines. J Biol Chem. 1979; 254(12):5155-60. View

2.
Pietromonaco S, Kerjaschki D, Binder S, Ullrich R, Farquhar M . Molecular cloning of a cDNA encoding a major pathogenic domain of the Heymann nephritis antigen gp330. Proc Natl Acad Sci U S A. 1990; 87(5):1811-5. PMC: 53573. DOI: 10.1073/pnas.87.5.1811. View

3.
Cheng C, Grima J, Stahler M, Guglielmotti A, Silvestrini B, Bardin C . Sertoli cell synthesizes and secretes a protease inhibitor, alpha 2-macroglobulin. Biochemistry. 1990; 29(4):1063-8. DOI: 10.1021/bi00456a031. View

4.
Haye K, FOSTER R, Goff J, Kaufman S . Endocytosis of alpha 2-macroglobulin is developmentally regulated during myogenesis. Dev Biol. 1986; 114(2):470-4. DOI: 10.1016/0012-1606(86)90211-3. View

5.
Shi D, Savona C, Gagnon J, Cochet C, Chambaz E, Feige J . Transforming growth factor-beta stimulates the expression of alpha 2-macroglobulin by cultured bovine adrenocortical cells. J Biol Chem. 1990; 265(5):2881-7. View